Sofosbuvir, velpatasvir, and voxilaprevir for treatment of recurrent hepatitis C virus infection after liver transplantation | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Sofosbuvir, velpatasvir, and voxilaprevir for treatment of recurrent hepatitis C virus infection after liver transplantation

Cardona-Gonzalez MG, Goldman JD, Narayan L, Brainard DM, Kowdley KV. Sofosbuvir, velpatasvir, and voxilaprevir for treatment of recurrent hepatitis C virus infection after liver transplantation. Hepatol Commun. 2018;2(12):1446-1450.

Publication Type:

Journal Article

Authors:

Cardona-Gonzalez, MG; Goldman, JD; Narayan, L; Brainard, DM; Kowdley, KV

Source:

Hepatol Commun, Volume 2, Issue 12, p.1446-1450 (2018)

Cited On:

Patients Who Develop Recurrent HCV Infection Post Liver Transplantation

Export Citation:

RIS Format

Top